Cambridge Investment Research Advisors, Inc.
Position in CGC — Canopy Growth Corp
CIK 1419186
FAIRFIELD, IA
Position in CGC
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$21,557
-$2,524 QoQ
Shares Held
22,716
+7.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $25,629,271 across 19 Drug Manufacturers - Specialty & Generic names. CGC ranks #19 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
69,851 | $5,298,198 | |
| 2 | ZTS |
Zoetis Inc.
|
30,836 | $3,645,123 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
5,575 | $3,305,863 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
95,052 | $2,862,966 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
122,762 | $2,774,421 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
45,555 | $2,700,044 | |
| 7 | VTRS |
Viatris Inc
|
113,737 | $1,536,586 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
61,872 | $1,284,462 |
All Filings in CGC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,557 | 22,716 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $24,081 | 21,124 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $27,364 | 18,743 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $20,649 | 16,926 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $14,033 | 15,421 | Shares | Sole | 2025-04-22 | |
| 2024-09-30 | $60,548 | 12,562 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $80,966 | 12,553 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $92,504 | 10,719 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||